Is there a role for fluorine 18 fluorodeoxyglucose-positron emission tomography and positron emission tomography/computed tomography in evaluating patients with mycobacteriosis? A systematic review

Journal of Computer Assisted Tomography

Volumn 35, Issue 3, 2011, Pages 387-393

  Treglia, Giorgio ^a   Taralli, Silvia ^a   Calcagni, Maria Lucia ^a   Maggi, Fabio ^a   Giordano, Alessandro ^a   Bonomo, Lorenzo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

mycobacteriosis; PET; PET CT; tuberculosis

Indexed keywords

COMPUTERIZED TOMOGRAPHY; DIAGNOSIS; DISEASE CONTROL; ELECTRONS; FLUORINE; PATIENT TREATMENT; POSITRONS;

CT (COMPUTED TOMOGRAPHY); FLUORINE-18; FLUORINE-18 FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHIES; LITERATURE SEARCH; MEDLINE DATABASE; MYCOBACTERIOSIS; POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHIES; POSITRON EMISSION TOMOGRAPHY/CT; SYSTEMATIC REVIEW; TUBERCULOSIS;

POSITRON EMISSION TOMOGRAPHY;

FLUORODEOXYGLUCOSE F 18;

COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; EVALUATION; HUMAN; LUNG NODULE; MEDICAL LITERATURE; MEDLINE; MYCOBACTERIOSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT RESPONSE;

EID: 79957833072     PISSN: 03638715     EISSN: 15323145     Source Type: Journal    
DOI: 10.1097/RCT.0b013e318219f810     Document Type: Review

References (20)

1. Grandjean L, Moore D. Tuberculosis in the developing world: recent advances in diagnosis with special consideration of the extensively drug-resistant tuberculosis. Curr Opin Infect Dis. 2008;21:454-461.
2. Winer-Muram HT. The solitary pulmonary nodule. Radiology. 2006;239:34-49.
3. Bakheet S, Powe J. Benign causes of 18-FDG uptake on whole-body imaging. Semin Nucl Med. 2000;28:352-358. (Pubitemid 28478048)
4. Kubota R, Yamada S, Kubota K, et al. Intratumoral distribution of fluorine-18-deoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med. 1992;33:1972-1980.
5. Ichiya Y, Kuwabara Y, Sasaki M, et al. FDG-PET in infectious lesions: the detection and assessment of lesion activity. Ann Nucl Med. 1996;10:185-191. (Pubitemid 26197404)
6. Goo JM, Im JG, Do KH, et al. Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases. Radiology. 2000;216:117-121. (Pubitemid 30434730)
7. 18F]FDG uptake and PCNA, Glut-1, and hexokinase-II expressions in cancers and inflammatory lesions of the lung. Neoplasia. 2005;7:369-379. (Pubitemid 40664226)
8. Castaigne C, Tondeur M, de Wit S, et al. Clinical value of FDG-PET/CT for the diagnosis of human immunodeficiency virus-associated fever of unknown origin: a retrospective study. Nucl Med Commun. 2009;30:41-47.
9. Hahm CR, Park HY, Jeon K, et al. Solitary pulmonary nodules caused by Mycobacterium tuberculosis and Mycobacterium avium complex. Lung. 2010;188:25-31.
10. 18F-FDG PET for the lymph node staging of non-small cell lung cancer in a tuberculosis-endemic country: is dual time point imaging worth the effort? Eur J Nucl Med Mol Imaging. 2008;35:1305-1315.
11. Hadley GP, Naude F. Malignant solid tumour, HIV infection and tuberculosis in children: an unholy triad. Pediatr Surg Int. 2009;25:697-701.
12. 18F-FDG PET in the diagnosis of pulmonary nodules with an initial standard uptake value less than 2.5. AJR Am J Roentgenol. 2008;191:475-479.
13. 18F-FDG PET-CT for determination of pulmonary tuberculoma activity. Eur J Nucl Med Mol Imaging. 2008;35:808-814.
14. Lee IS, Lee JS, Kim SJ, et al. Fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography imaging in pyogenic and tuberculous spondylitis: preliminary study. J Comput Assist Tomogr. 2009;33:587-592.
15. Sathekge MM, Maes A, Pottel H, et al. Dual time-point FDG PET-CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area. S Afr Med J. 2010;100:598.
16. Sathekge M, Maes A, Kgomo M, et al. Impact of FDG PET on the management of TBC treatment. A pilot study. Nuklearmedizin. 2010;49:35-40.
17. Demura Y, Tsuchida T, Uesaka D, et al. Usefulness of 18F- fluorodeoxyglucose positron emission tomography for diagnosing disease activity and monitoring therapeutic response in patients with pulmonary mycobacteriosis. Eur J Nucl Med Mol Imaging. 2009;36:632-639.
18. Kim SJ, Kim IJ, Suh KT, et al. Prediction of residual disease of spine infection using F-18 FDG PET/CT. Spine. 2009;34:2424-2430.
19. 11C-choline in lung cancer and pulmonary tuberculosis: a positron emission tomography study. Chest. 2003;124:893-901. (Pubitemid 37123306)
20. 18F-FDG. J Nucl Med. 2008;49:186-194. (Pubitemid 351225655)